BLPH News

Advanced Inhalation Therapies (AIT), which is developing inhaled nitric oxide drug-device therapies for respiratory infections, filed on Tuesday with the SEC to raise up to $36 million in an initial public offering. The Rehovot, Israel-based company, which was founded in 2011, plans to list on the Nasdaq under the symbol AITP. Aegis Capital is the sole bookrunner on the deal...read more

Five companies had below-average returns and brought the number 2015 IPOs up to 22, a 39% decline from this time last year... IPO highlights during the week of February 9, 2015 • ...read more

Bellerophon Therapeutics, which is developing drug-device therapies for pulmonary and cardiac diseases, raised $60 million by offering 5 million shares at $12, below the range of $14 to $16. The company had originally planned to sell 4 million shares. Bellerophon Therapeutics plans to list on the NASDAQ under the symbol BLPH. Leerink Partners and Cowen & Company acted as lead...read more

Twelve deals are on the calendar to raise $1.2 billion, which would make it the year's biggest week for IPOs by proceeds and count. However, those numbers could decline if the week ahead is similar to last week, which saw ...read more